These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 688252)
1. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo. Bender RA; Nichols AP; Norton L; Simon RM Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252 [TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia. Chello PL; Sirotnak FM; Dorick DM; Moccio DM Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921 [TBL] [Abstract][Full Text] [Related]
3. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia. Chello PL; Sirotnak FM Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551 [TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia. Klubes P; Cerna I Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161 [TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784 [TBL] [Abstract][Full Text] [Related]
6. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy. Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122 [TBL] [Abstract][Full Text] [Related]
7. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Kano Y; Ohnuma T; Okano T; Holland JF Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052 [TBL] [Abstract][Full Text] [Related]
8. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo. Chello PL; Sirotnak FM; Dorick DM Cancer Res; 1979 Jun; 39(6 Pt 1):2106-12. PubMed ID: 445407 [No Abstract] [Full Text] [Related]
9. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice. Samuels LL; Straw JA Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia. Wampler GL; Carter WH; Campbell ED; Goldman ID Cancer Treat Rep; 1987 Jun; 71(6):581-91. PubMed ID: 3581096 [TBL] [Abstract][Full Text] [Related]
11. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells. Capizzi RL Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells. Chang BK; Huang AT; Joines WT Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530 [TBL] [Abstract][Full Text] [Related]
13. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models. Sirotnak FM; Moccio DM; Dorick DM Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment. Chu BC; Howell SB J Pharmacol Exp Ther; 1981 Nov; 219(2):389-93. PubMed ID: 6974776 [TBL] [Abstract][Full Text] [Related]
15. Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high-dose methotrexate-folinic acid "rescue" protocols. Goldman ID; Gupta V; White JC; Loftfield S Cancer Res; 1976 Jan; 36(1):276-9. PubMed ID: 1248006 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside. Presant CA; Vietti TJ; Valeriote F; Coulter DM J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666 [TBL] [Abstract][Full Text] [Related]
18. The influence of recombinant human tumor necrosis factor-alpha, alone and in combination with cyclophosphamide or methotrexate, on leukemia L1210 and normal hematopoiesis in mice. Warzocha K; Robak T; Korycka A; Graczyk J; Pakulska W; Gałazka G; Kłysik J Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):587-95. PubMed ID: 1841555 [TBL] [Abstract][Full Text] [Related]
19. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388. Góra-Tybor J; Robak T Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959 [TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model. Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]